Doctors Note Logo

Published on: 9/24/2026

What is the best antihistamine for a runny nose?

Second-generation antihistamines such as cetirizine (Zyrtec), loratadine (Claritin), and fexofenadine (Allegra) are generally the best first choices for an allergy-related runny nose because they relieve symptoms with far less drowsiness than older options, while first-generation antihistamines like diphenhydramine (Benadryl) or chlorpheniramine may dry secretions faster but cause sedation. Cetirizine tends to work quickest and strongest, loratadine is the least sedating for daytime use, and azelastine nasal spray can target nasal drip directly, though antihistamines do little for a runny nose caused by a cold or non-allergic triggers. Your age, other medications, pregnancy status, and whether congestion or sneezing accompanies the drip all change which option is safest and most effective, so there are several important factors to consider below before choosing.

Because a runny nose can stem from allergies, viral infections, sinus inflammation, or non-allergic rhinitis, picking the right medication starts with understanding the likely cause rather than guessing at the pharmacy shelf. Take a free, instant, online symptom check to clarify what may be driving your symptoms and get guidance on sensible next steps.

Last reviewed for medical accuracy: 09/24/2026

answer background

Explanation

Best Antihistamine for Runny Nose

A persistent runny nose can disrupt daily life, whether it’s due to seasonal allergies, a cold, or other triggers. Antihistamines are a go-to solution for many, but with so many options on the market, choosing the right one can feel overwhelming. This guide breaks down how antihistamines work, compares key classes, highlights top over-the-counter choices, and offers practical tips for managing a runny nose effectively.

How Antihistamines Work

When your body encounters an allergen (like pollen, dust mites or pet dander), it releases histamine—a chemical that causes blood vessels to dilate, nasal tissues to swell, and mucus to flow. Antihistamines block histamine H₁ receptors, reducing:

  • Sneezing
  • Nasal congestion
  • Runny nose
  • Itchy or watery eyes

By targeting histamine, these medications help restore comfort and keep mucus production in check.

First-Generation vs Second-Generation Antihistamines

Not all antihistamines are created equal. They fall into two main categories:

First-Generation Antihistamines

  • Diphenhydramine (Benadryl®)
  • Chlorpheniramine (Chlor-Trimeton®)

Pros

  • Fast-acting relief
  • Widely available

Cons

  • Significant drowsiness
  • Dry mouth, urinary retention
  • Short duration (requires multiple daily doses)

Second-Generation Antihistamines

  • Cetirizine (Zyrtec®)
  • Loratadine (Claritin®)
  • Fexofenadine (Allegra®)

Pros

  • Less sedation
  • Longer lasting (once-daily dosing)
  • Fewer anticholinergic side effects

Cons

  • May take longer to reach full effect (1–3 hours)
  • Cost can be higher than first-generation options

For most people seeking the best antihistamine for runny nose with minimal drowsiness, second-generation agents are recommended.

Top Over-the-Counter Options

Here’s a closer look at the most popular second-generation antihistamines and how they stack up for runny nose relief:

  • Cetirizine (Zyrtec®)

    • Onset: 1 hour
    • Duration: 24 hours
    • Pros: Rapid relief, effective for nasal and eye symptoms
    • Cons: Mild sedation in some users
  • Loratadine (Claritin®)

    • Onset: 1–3 hours
    • Duration: 24 hours
    • Pros: Very low risk of drowsiness, good daily control
    • Cons: May be slightly less potent for severe symptoms
  • Fexofenadine (Allegra®)

    • Onset: 1 hour
    • Duration: 24 hours
    • Pros: Virtually non-sedating, strong relief of nasal symptoms
    • Cons: Absorption may be reduced if taken with fruit juice

How to Choose

  • If daytime alertness is critical, try fexofenadine.
  • For fast relief and balanced control of nasal and ocular symptoms, cetirizine is a solid choice.
  • For mild symptoms or budget concerns, loratadine works well.

Intranasal Antihistamines: A Targeted Approach

Oral antihistamines help systemically, but if runny nose is your main complaint, intranasal antihistamine sprays can be more directly effective:

  • Azelastine (Astelin®, Astepro®)

    • Onset: 15–30 minutes
    • Duration: 12 hours
    • Pros: Direct application to nasal tissues, superior relief of nasal discharge and congestion
    • Cons: Slightly higher cost, need for prescription in some regions
  • Olopatadine (Patanase®)

    • Onset: 30 minutes
    • Duration: 12 hours
    • Pros: Well-tolerated, minimal systemic side effects
    • Cons: Prescription only

Intranasal sprays work faster at the source and can be combined with oral antihistamines for stubborn symptoms. Always prime the spray before first use and follow instructions to avoid irritation.

Tips for Effective Use

To get the most benefit and minimize side effects:

  • Take second-generation antihistamines once daily, ideally at the same time each day.
  • For seasonal allergies, start treatment 1–2 weeks before pollen season.
  • Avoid alcohol and other sedating medications if you’re on diphenhydramine or cetirizine.
  • If using fexofenadine, take with water and avoid fruit juices for 2 hours around dosing.
  • For intranasal sprays, blow your nose gently before application.
  • Tilt your head forward slightly and aim the spray toward the outer wall of your nostril.

Additional Considerations

  • Combination Products
    Some OTC formulas combine antihistamines with decongestants (e.g., loratadine + pseudoephedrine). They can offer extra relief but may raise blood pressure or cause jitteriness.
  • Underlying Causes
    A runny nose can also stem from non-allergic rhinitis, infection, or structural issues. If you’ve tried multiple antihistamines without relief, consider exploring other diagnoses.

If you’re uncertain about your symptoms or which medication to choose, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you sort through possible causes and suggest next steps.

When to Seek Medical Advice

Most runny noses improve with home remedies and OTC antihistamines. However, it’s vital to speak to a doctor if you experience:

  • High fever or severe headache
  • Facial pain or pressure lasting more than 10 days
  • Blood in nasal discharge
  • Shortness of breath or chest tightness
  • Symptoms interfering with daily life despite treatment

Always discuss new or worsening symptoms—especially anything life-threatening or serious—with a healthcare professional promptly.


Choosing the best antihistamine for runny nose comes down to balancing efficacy, side effects, and convenience. Second-generation oral antihistamines like cetirizine, loratadine, and fexofenadine are first-line for most, while intranasal sprays such as azelastine offer targeted relief. Use these tips to guide your selection, consider a free symptom check with Ubie if you need further clarity, and don’t hesitate to speak to a doctor for anything that feels out of the ordinary.

(References)

  • * Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, Dawson DE, Dykewicz MS, Hackell JM, Han JK, Ishman SL, Krouse HJ, Malekzadeh S, Mims JW, Omole FS, Reddy WD, Wallace DV, Walsh SA, Warren BE, Wilson MN, Nnacheta LC, Guideline Otolaryngology Development Group. AAO-HNSF. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015 Feb;152(1 Suppl):S1-43. doi: 10.1177/0194599814561600. PMID: 25644617.

  • * Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A, Toppila-Salmi S. Allergic rhinitis. Nat Rev Dis Primers. 2020 Dec 3;6(1):95. doi: 10.1038/s41572-020-00227-0. Epub 2020 Dec 3. PMID: 33273461.

  • * Czech EJ, Overholser A, Schultz P. Allergic Rhinitis. Prim Care. 2023 Jun;50(2):159-178. doi: 10.1016/j.pop.2023.01.003. Epub 2023 Mar 8. PMID: 37105599.

  • * Tosca MA, Trincianti C, Naso M, Nosratian V, Ciprandi G. Treatment of Allergic Rhinitis in Clinical Practice. Curr Pediatr Rev. 2024;20(3):271-277. doi: 10.2174/1573396320666230912103108. PMID: 37702169.

  • * Pagel JML, Mattos JL. Allergic Rhinitis and Its Effect on Sleep. Otolaryngol Clin North Am. 2024 Apr;57(2):319-328. doi: 10.1016/j.otc.2023.09.003. Epub 2023 Oct 20. PMID: 37867109.

  • * Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic Rhinitis: A Review. JAMA. 2024 Mar 12;331(10):866-877. doi: 10.1001/jama.2024.0530. PMID: 38470381.

  • * Czech EJ, Overholser A, Schultz P. Allergic Rhinitis. Med Clin North Am. 2024 Jul;108(4):609-628. doi: 10.1016/j.mcna.2023.08.013. PMID: 38816106.

  • * Torres MI, Gil-Mata S, Bognanni A, Ferreira-da-Silva R, Yepes-Nuñez JJ, Lourenço-Silva N, Cardoso-Fernandes A, Ferreira A, Ferreira-Cardoso H, Portela D, Teles J, Kvedariene V, Torres MJ, Klimek L, Pfaar O, Brussino L, Zuberbier T, Fonseca JA, Schünemann H, Bousquet J, Sousa-Pinto B, Vieira RJ, Allergic Rhinitis and its Impact on Asthma 2024 Guideline Panel. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis. J Allergy Clin Immunol Pract. 2024 Dec;12(12):3404-3418. doi: 10.1016/j.jaip.2024.09.001. Epub 2024 Sep 7. PMID: 39251016.

  • * Cardona V, Salvany-Pijuan A, Pereira-González J. Allergic rhinitis. Med Clin (Barc). 2025 Jun 13;164(11):106916. doi: 10.1016/j.medcli.2025.106916. Epub 2025 Apr 10. PMID: 40215921.

  • * Vieira RJ, Sousa-Pinto B, Bousquet J, Schünemann HJ, Zuberbier T, Bognanni A, Togias A, Samolinski B, Valiulis A, Williams S, Bedbrook A, Czarlewski W, Torres MJ, Shamji MH, Morais-Almeida M, Canonica GW, Vecillas LL, Dykewicz MS, Jacomelli C, Klimek L, Leemann L, Lourenço O, Papadopoulos NG, Pereira AM, Savouré M, Toppila-Salmi SK, Ventura MT, Yepes-Nuñez JJ, Cruz AA, Ciprandi G, Gemicioglu B, Giovannini M, Gradauskiene B, Jartti T, Jeseňák M, Kuna P, Kvedariene V, Larenas-Linnemann DE, Latiff AHA, Mohammad Y, Ohta K, Mahesh PA, Pali-Schöll I, Pfaar O, Regateiro FS, Roche N, Taborda-Barata L, Ulrik CS, Viegi G, Zhang L, Haahtela T, Cherrez-Ojeda I, Ivancevich JC, Khaltaev N, Yorgancioglu A, Abdullah B, Al-Ahmad M, Al-Nesf MA, Amaral R, Asllani J, Bergmann KC, Bernstein JA, Blaiss MS, Toskala E, Carreiro-Martins P, Casale T, Cecchi L, Fiocchi A, Giuliano AFM, Christoff G, Cirule I, de Sousa JC, Costa EM, Devillier P, Hossny E, Iinuma T, Ispayeva Z, Julge K, Kaidashev I, Bennoor KS, Kraxner H, Kull I, Kulus M, Kupczyk M, Kurchenko A, La Grutta S, Miculinic N, Tuyet LLT, Lee SM, Montefort S, Moreira A, Mullol J, Nadif R, Nakonechna A, Neffen HE, Niedoszytko M, O'Hehir RE, Ogulur I, Okamoto Y, Olze H, Palomares O, Panzner P, Patella V, Pitsios C, Puggioni F, Quirce S, Ramonaité A, Repka-Ramirez MS, Roberts G, Robles-Velasco K, Rottem M, Salapatas M, Sastre J, Scichilone N, Sisul JC, Solé D, Soto-Martinez ME, Sova M, Tantilipikorn P, Todo-Bom A, Tsaryk V, Tsiligianni I, Urrutia-Pereira M, Valovirta E, Vasankari T, Wallace D, Wang Y, Worm M, Yusuf OM, Gil-Mata S, Marques-Cruz M, Mahboub B, Romano A, Aberer W, Artesani MC, Azzolini E, Barreto B, Bartra J, Becker S, Beghe B, Boner A, Borowiack E, Bouchard J, Brussino L, Buhl R, Catamerò F, Charpin D, Chavannes NH, Chełmińska M, Cheng L, Chkhartishvili E, Cho SH, Chong-Neto HJ, Chu DK, Cingi C, Compalati E, Costa RA, Cvetkovski B, Cardona V, D'Amato G, Davies JM, Di Bona D, Gonzalez Diaz SN, Dimou MV, Doulaptsi M, Ferreira-da-Silva R, Gawlik R, Calvo-Gil M, Gómez MR, Gotua M, Grigoreas C, Guzman MA, House R, Hyland M, Ierodiakonou D, Karavelia A, Keith P, Kisiel M, Kosak TS, Kosnik M, Koyuncu IV, Kritikos V, Litynska J, Lombardi C, Louis G, Luo X, Martini M, Meço C, Mesonjesi E, Mihaltan F, Moniuszko M, Naclerio RN, Neisinger S, Ollert M, Ordak M, Paoletti G, Parmelli E, Perdomo-Flores EA, Pereira H, Pérez JMF, Pham-Thi N, Prokopakis E, Ribeiro-Vaz I, Rolla G, Romantowski J, Rombaux P, Rouadi PW, Ryan D, Sadowska E, Sakurai D, Salameh L, Serrano E, Da Silva J, Soyka MB, Specjalski K, Tomic-Spiric V, Stevanovic K, Subramaniam A, Thomander T, Tong W, Vachova M, van Hage M, Wagenmann M, Ko FWS, Werminghaus P, Xepapadaki PV, Xiang YK, Yang Q, Zhang H, Zuberbier J, Fonseca JA. Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments. Allergy. 2026 Jun;81(6):1947-1970. doi: 10.1111/all.70305. Epub 2026 Mar 24. PMID: 41877472; PMCID: PMC13256267.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.